| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/26/1989 | EP0313104A2 Purification, production and use of tumor necrosis factors |
| 04/26/1989 | EP0312913A2 Use of paf-antagonists for the preparation of a medicament and method for the determination of their binding-activity |
| 04/26/1989 | EP0312543A1 $i(IN SITU) ACTIVE COMPOUND ASSEMBLY |
| 04/26/1989 | CN1032490A Pharmaceutical preparation and process for same |
| 04/25/1989 | US4824673 New drugs based on extracts of algae, and corresponding formulations |
| 04/25/1989 | US4824664 Effervescent couples, histamine H2 -antagonist effervescent compositions containing them and their preparation |
| 04/25/1989 | CA1253076A1 Peritoneal dialysis and compositions for use therein |
| 04/20/1989 | WO1989003219A1 Improved method for treatment of gastrointestinal disorders |
| 04/20/1989 | WO1989003211A1 Treatment of cocaine addiction |
| 04/19/1989 | EP0312222A1 Treatment of diseases caused by viruses |
| 04/18/1989 | US4822605 Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
| 04/12/1989 | EP0311582A1 Pharmaceutical preparation with extended release of a dihydropyridine and a beta-adrenoreceptor antagonist and a process for the preparation thereof |
| 04/12/1989 | CN1032296A Synergistic interplay of lymphokines and dsrnas |
| 04/11/1989 | US4820724 Dual phase solvent carrier system |
| 04/11/1989 | US4820523 Pharmaceutical composition |
| 04/06/1989 | WO1989002735A1 Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloalkanes |
| 04/06/1989 | WO1989002734A1 Vasoconstrictive substances in combination with cytotoxic agents |
| 04/05/1989 | EP0310541A1 Antigestagenic and antioestrogenic compounds for the introduction of labour and interruption of pregnancy, as well as for the treatment of gynecologic disorders |
| 04/05/1989 | EP0310476A1 Inhibitory or destructible composition of at least one unicellular living being containing fluor F- and lithium li+ |
| 04/05/1989 | EP0310179A2 Tetrahydrocarbazole esters |
| 04/05/1989 | EP0309801A2 Use of thromboxane A2 antagonists for the manufacture of a medicament for improving post-ischemic myocardial dysfunction |
| 03/30/1989 | DE3730556A1 Multilipid-based medicine |
| 03/29/1989 | EP0309100A2 Use of amylin or CGRP for the treatment of diabetes mellitus |
| 03/29/1989 | EP0308475A1 Adjuvant for certain antimitotic chemicals, obtained from vibrio cholerae |
| 03/29/1989 | EP0308460A1 A composition for the topical treatment of glaucoma or ocular hypertension. |
| 03/28/1989 | CA1251732A1 Pharmaceutical compositions comprising an antiprogestomimetic substance and a uterotonic substance |
| 03/22/1989 | EP0307480A1 Process for preparing antibody complex |
| 03/15/1989 | EP0306984A1 Preservative system for ophtalmic formulations |
| 03/15/1989 | EP0306943A2 Immunconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
| 03/14/1989 | US4812446 Pharmaceutical products providing enhanced analgesia |
| 03/14/1989 | US4812444 Dehydration of hydrous matter using anhydrous glycosylfructose |
| 03/14/1989 | CA1251137A1 Analgesic and anti-inflammatory compositions comprising diphenhydramineand methods of using same |
| 03/09/1989 | WO1989001774A1 Pharmaceutical compositions |
| 03/08/1989 | EP0306303A1 Anti-viral neoantigen antibodies and anti-idiotypic antibodies induced thereby as anti-viral agents |
| 03/08/1989 | EP0306060A2 Pharmaceutical products providing enhanced analgesia |
| 03/08/1989 | CN1031529A Pharmaceutical compositions |
| 03/07/1989 | US4810827 Dehydration of hydrous matter using anhydrous aldohexose |
| 03/01/1989 | EP0305194A2 Veterinary composition |
| 02/28/1989 | US4808627 Method of preventing or treating toxemia in pregnancy using a thromboxane A2 receptor antagonist |
| 02/28/1989 | US4808572 α-Hydroxy thioethers |
| 02/23/1989 | WO1989001629A1 Human ovarian tumor-associated antigen specific for monoclonal antibody ov-tl3 |
| 02/23/1989 | WO1989001341A1 Methods and compositions for the treatment of lung conditions |
| 02/23/1989 | WO1989001340A1 Method for treating malignancy and autoimmune disorders in humans |
| 02/23/1989 | WO1989001338A1 Immunotherapeutic methods and compositions for the treatment of diseases of viral origin, including acquired immune deficiency syndrome |
| 02/21/1989 | US4806548 4-phenyl-tetrahydroisoquinoline antidepressant, cimetidine, and ranitidine; histamine h-2-antagonists |
| 02/16/1989 | DE3826419A1 Die wundheilung foerderndes arzneimittelpraeparat und verfahren zu seiner herstellung Wound-healing promoting arzneimittelpraeparat and process for its preparation |
| 02/14/1989 | CA1250090A1 Pharmaceutical composition having an excellent absorption property |
| 02/09/1989 | WO1989000848A1 Method for the treatment of body tissues and the administration of drugs thereto |
| 02/09/1989 | WO1988009660A3 Chemical prevention or reversal of cataract by phase separation inhibitors |
| 02/08/1989 | EP0302473A2 Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
| 02/08/1989 | EP0302263A2 Therapeutic composition for combatting AIDS |
| 02/08/1989 | EP0145775B1 A METHOD OF TREATING INTERFERON SENSITIVE DISEASES, AND A METHOD AND A DEVICE FOR PREPARING A $g(g)-INTERFERON CONTAINING PREPARATION |
| 02/01/1989 | EP0302008A2 5HT-3 antagonists for prevention of dependence |
| 02/01/1989 | EP0301392A1 Pharmaceutical composition for intranasal administration comprising GH - Releasing hormone, a cholinergic agonist and in case a bile salt |
| 02/01/1989 | EP0301122A1 Use of soybean kunitz type trypsin and derivatives in the preparation of medicaments and agent comprising the same |
| 01/31/1989 | US4801609 Mercapto-acylamino acid antihypertensives |
| 01/31/1989 | US4801586 N-heterocycles |
| 01/26/1989 | WO1989000581A1 Lectines fixing beta-d-galactoside |
| 01/26/1989 | WO1989000427A1 Pharmaceutical therapeutic use of a glutathione derivative |
| 01/26/1989 | WO1989000426A1 Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
| 01/25/1989 | EP0300675A2 Method for the improvement of cyclosporine therapy |
| 01/25/1989 | EP0299975A1 Composition for arresting angiogenesis and capillary, cell or membrane leakage. |
| 01/24/1989 | US4800081 Calcium influx blocker synergistic with interferon or cyclic nucleotide modulator |
| 01/19/1989 | DE3822792A1 Use of 5-HT3 antagonists |
| 01/19/1989 | DE3722647A1 Galenische verwendung eines tripeptids als arzneimittel Pharmaceutical use of a tripeptide as drug |
| 01/18/1989 | EP0299467A1 Mitotic inhibitor and method for preventing posterior lens capsule opacification after extracapsular extraction |
| 01/18/1989 | EP0299376A2 Prostanoid compositions and methods for reducing blood vessel dysfunction |
| 01/11/1989 | EP0298280A2 Animal derived cell with antigenic protein introduced therein |
| 01/10/1989 | US4797410 Calcium channel blocking compounds |
| 01/10/1989 | US4797388 Pharmaceutical compositions with galactitol as carrier |
| 01/04/1989 | EP0297630A1 Medicine containing local anesthetics and nucleosides |
| 01/03/1989 | CA1248094A1 Antitumoral agents, such as the daunorubicine with enhanced effectiveness, their preparation process and a process to enhance the effectiveness of the antitumoral agents |
| 01/03/1989 | CA1248024A1 Treatments employing drug-containing matrices for introduction into cellular lesion areas |
| 12/27/1988 | US4794111 Hypotensive agents |
| 12/27/1988 | US4793998 Stabilized drug compositions |
| 12/21/1988 | EP0296097A2 Medicine containing inhibitors of the progesterone synthesis of the trilostane or epostane type and antigestagens |
| 12/15/1988 | WO1988009675A1 Inhibition of arachidonic acid metabolism |
| 12/15/1988 | WO1988009660A2 Chemical prevention or reversal of cataract by phase separation inhibitors |
| 12/15/1988 | WO1988009656A1 Cough/cold mixtures comprising non-sedating antihistamine drugs |
| 12/15/1988 | WO1988009605A2 Traumatic and ischemic brain injury treatment with opiate-receptor antagonists |
| 12/15/1988 | WO1988009603A2 Central nervous system injury treatment with opiate-receptor antagonists |
| 12/14/1988 | EP0294601A2 Transdermal delivery of pharmaceuticals |
| 12/14/1988 | EP0294380A1 Stimulation of angiogenesis |
| 12/13/1988 | US4791099 Administering sex hormones and anabolic hormones |
| 12/13/1988 | CA1246454A1 Analgesic and anti-inflammatory compositions comprising xanthine and methods of using same |
| 12/13/1988 | CA1246449A1 Drug kit or drug composition for ischaemic damage |
| 12/07/1988 | EP0294016A2 Factor XIIIa inhibitor compounds useful for thrombolytic therapy |
| 12/07/1988 | EP0293563A1 Combined preparation, especially against inflammatory processes |
| 12/06/1988 | US4789662 Method for the treatment of periodontal pockets with a composition comprising collagen and an antiseptic or anti-inflammatory substance |
| 12/01/1988 | WO1988009376A1 Method and compositions for making acsf and acsf antagonists |
| 12/01/1988 | WO1988009182A1 Hepatic blocking agents |
| 11/29/1988 | US4788063 Drug delivery system |
| 11/09/1988 | EP0290296A2 Liposomal formulations with a high antineoplastic agent/lipid ratio |
| 11/09/1988 | EP0289533A1 IgE-INDUCED REGULANT (EIR) COMPOSITIONS |
| 11/08/1988 | US4783465 Cough/cold mixtures comprising non-sedating antihistamine drugs |
| 11/08/1988 | US4783450 Use of commercial lecithin as skin penetration enhancer |
| 11/08/1988 | CA1244344A1 Tumor localization and therapy with labeled antibodies and antibody fragments specific to tumor- associated markers |
| 11/03/1988 | WO1988008302A1 Cough/cold mixtures comprising non-sedating antihistamine drugs |
| 10/26/1988 | EP0287615A1 (ex vivo)-effector cell activation for target cell killing |
| 10/25/1988 | US4780313 Antitumor agents |